Education
About Us
Working with TipRanks
Follow Us
Ann Calby Miller Insider Profile
11 Followers
Ann Calby Miller, Director at Inovio Pharmaceuticals, holds 7.71K shares in Inovio Pharmaceuticals (Ticker: INO), holds 40.73K shares in Puma Biotechnology (Ticker: PBYI), holds ― shares in Allena Pharmaceuticals (Ticker: ALNAQ).
Ann Calby Miller has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ann Calby Miller holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 11, 2021 - Jun 11, 2022
Return:+77.10%
The most profitable trade made by Ann Calby Miller
Ann Calby Miller's Trading History
Inovio Pharmaceuticals
May 16, 2024
Director
Uninformative Buy
28.31K
$15.03K
Puma Biotechnology
Jun 17, 2021
Director
Uninformative Buy
―
$142.97K
Allena Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Ann Calby Miller's performance on stock
You May Also Like
Ann Calby Miller insider profile FAQ
What is the percentage of profitable transactions made by Ann Calby Miller?
The percentage of profitable transactions made by Ann Calby Miller is ―.
What is the average return per transaction made by Ann Calby Miller?
The average return per transaction made by Ann Calby Miller is ―.
What stocks does Ann Calby Miller hold?
Ann Calby Miller holds: INO, PBYI, ALNAQ stocks.
What was Ann Calby Miller’s latest transaction?
Ann Calby Miller latest transaction was an Uninformative Buy of $28.31K.
What was Ann Calby Miller's most profitable transaction?
Ann Calby Miller’s most profitable transaction was an Informative Sell of PBYI stock on June 11, 2021. The return on the trade was 77.10%.
What is Ann Calby Miller's role in Inovio Pharmaceuticals?
Ann Calby Miller's role in Inovio Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.